(Q33790830)

29 July 2017

1 reference

title

Amyloid beta peptide membrane perturbation is the basis for its biological effects (English)

1 reference

29 July 2017

Kanfer JN

1

1 reference

29 July 2017

Sorrentino G

series ordinal

2

1 reference

29 July 2017

Sitar DS

series ordinal

3

1 reference

29 July 2017

language of work or name

1 reference

1 December 1999

1 reference

29 July 2017

Neurochemical Research

1 reference

29 July 2017

24

1 reference

29 July 2017

12

1 reference

29 July 2017

1621-1630

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1021172620295

29 July 2017

0 references

cites work

Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells

1 reference

12 December 2020

Prospective study of increased platelet membrane fluidity as a risk factor for Alzheimer's disease: results at 5 years.

1 reference

12 December 2020

Reduction of adenosine A1-receptors in the perforant pathway terminal zone in Alzheimer hippocampus

1 reference

12 December 2020

Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in the neuronal cell line, HN2-5.

1 reference

12 December 2020

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

12 December 2020

Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.

1 reference

12 December 2020

The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets

1 reference

12 December 2020

beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus.

1 reference

12 December 2020

Eicosapentaenoic acid incorporation in membrane phospholipids modulates receptor-mediated phospholipase C and membrane fluidity in rat ventricular myocytes in culture

1 reference

12 December 2020

Hippocampal membrane alteration in Alzheimer's disease.

1 reference

12 December 2020

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

1 reference

12 December 2020

Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease.

1 reference

12 December 2020

Serpins inhibit the toxicity of amyloid peptides

1 reference

12 December 2020

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

12 December 2020

Is amyloid beta-protein glycated in Alzheimer's disease?

1 reference

12 December 2020

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

12 December 2020

Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study

1 reference

12 December 2020

Interaction of amyloid beta protein (25-35) with tachykinin receptors

1 reference

12 December 2020

Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus

1 reference

12 December 2020

Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

1 reference

12 December 2020

Activation of LA-N-2 cell phospholipase D by amyloid beta protein (25-35).

1 reference

12 December 2020

An amyloid peptide, beta A4 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells

1 reference

12 December 2020

Adrenergic receptors in aging and Alzheimer's disease: Decreased α2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex

1 reference

12 December 2020

Altered mitochondrial membrane fluidity in AD brain.

1 reference

12 December 2020

beta-Amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus.

1 reference

12 December 2020

Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.

1 reference

12 December 2020

Loss of high-affinity alpha 2-adrenoceptors in Alzheimer's disease: an autoradiographic study in frontal cortex and hippocampus

1 reference

12 December 2020

Regional levels of brain phospholipase Cgamma in Alzheimer's disease.

1 reference

12 December 2020

The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes

1 reference

12 December 2020

Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.

1 reference

12 December 2020

Beta amyloid toxicity does not require RAGE protein

1 reference

12 December 2020

Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation

1 reference

12 December 2020

Activation of LA-N-2 cell phospholipases by single alanine substitution analogs of amyloid beta peptide (25-35)

1 reference

12 December 2020

GABAA receptor complex function in frontal cortex membranes from control and neurological patients

1 reference

12 December 2020

Specificity in recognition of amyloid-beta peptide by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells

1 reference

12 December 2020

Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity

1 reference

12 December 2020

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain.

1 reference

12 December 2020

Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons.

1 reference

12 December 2020

Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies

1 reference

12 December 2020

Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication.

1 reference

12 December 2020

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

1 reference

12 December 2020

A femtomolar-acting neuroprotective peptide

1 reference

12 December 2020

Normal densities of 5-HT3 receptor recognition sites in Alzheimer's disease.

1 reference

12 December 2020

Preservation of kappa 1 opioid receptor recognition site density and regulation by G-proteins in the temporal cortex of patients with Alzheimer's disease

1 reference

12 December 2020

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

1 reference

12 December 2020

Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes

1 reference

12 December 2020

High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease.

1 reference

12 December 2020

Platelet membrane abnormality in Alzheimer's disease

1 reference

12 December 2020

Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.

1 reference

12 December 2020

All-D-enantiomers of beta-amyloid exhibit similar biological properties to all-L-beta-amyloids.

1 reference

12 December 2020

1 reference

12 December 2020

Evidence that glypican is a receptor mediating beta-amyloid neurotoxicity in PC12 cells.

1 reference

12 December 2020

beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease

1 reference

12 December 2020

Amyloid beta protein does not interact with tachykinin receptors coupled to inositol phospholipid hydrolysis in human astrocytoma cells.

1 reference

12 December 2020

Intracellular membranes are more fluid in platelets of Alzheimer's disease patients

1 reference

12 December 2020

Opioid receptor density changes in Alzheimer amygdala and putamen

1 reference

12 December 2020

(-)Nicotine inhibits the activations of phospholipases A2 and D by amyloid beta peptide.

1 reference

12 December 2020

Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis

1 reference

12 December 2020

Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids

1 reference

12 December 2020

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

1 reference

12 December 2020

Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.

1 reference

12 December 2020

beta-Amyloid (25-35) or substance P stimulates [3H]MK-801 binding to rat cortical membranes in the presence of glutamate and glycine.

1 reference

12 December 2020

Membrane instability, plasmalogen content, and Alzheimer's disease.

1 reference

12 December 2020

Molecular neurobiology of Alzheimer's disease (syndrome?).

1 reference

12 December 2020

Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease

1 reference

12 December 2020

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

1 reference

12 December 2020

Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate

1 reference

12 December 2020

Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease.

1 reference

12 December 2020

Aggregation state-dependent binding of beta-amyloid peptide to protein and lipid components of rat cortical homogenates.

1 reference

12 December 2020

The trophic effect of β-amyloid 25–35 peptide is not mediated by NK1 or bombesin receptors

1 reference

12 December 2020

Cholesterol as modulator of receptor function.

1 reference

12 December 2020

Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor

1 reference

12 December 2020

Glycation and microglial reaction in lesions of Alzheimer's disease.

1 reference

12 December 2020

Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction

1 reference

12 December 2020

Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes.

1 reference

12 December 2020

beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease

1 reference

12 December 2020

Phospholipase C isozymes in the human brain and their changes in Alzheimer's disease.

1 reference

12 December 2020

Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide

1 reference

12 December 2020

beta-Amyloid peptide decreases membrane fluidity.

1 reference

12 December 2020

Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease.

1 reference

12 December 2020

AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer disease. Evidence for hippocampal plasticity.

1 reference

12 December 2020

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

1 reference

12 December 2020

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Beta-adrenoceptor density and subtype distribution in cerebellum and hippocampus from patients with Alzheimer's disease.

1 reference

12 December 2020

Stimulation of phospholipase C activity by norepinephrine, t-ACPD and bombesin in LA-N-2 cells

1 reference

12 December 2020

Receptor-mediated specific biological activity of a beta-amyloid protein fragment for NK-1 substance P receptors

1 reference

12 December 2020

1 reference

12 December 2020

Role of lipid-induced changes in plasma membrane in the biophysical shunt theory of psychopathology.

1 reference

12 December 2020

Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease

1 reference

12 December 2020

Phospholipases as mediators of amyloid beta peptide neurotoxicity: an early event contributing to neurodegeneration characteristic of Alzheimer's disease.

1 reference

12 December 2020

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.

1 reference

12 December 2020

Dietary oxidized linoleic acid modifies lipid composition of rat liver microsomes and increases their fluidity

1 reference

12 December 2020

Brain membrane fluidity and lipid peroxidation in Alzheimer's disease.

1 reference

12 December 2020

Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders

1 reference

12 December 2020

Adrenergic receptors in Alzheimer's disease brain: selective increases in the cerebella of aggressive patients.

1 reference

12 December 2020

Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease.

1 reference

12 December 2020

The cholinergic system in Alzheimer's disease

1 reference

12 December 2020

Peptides in membranes: tipping the balance of membrane stability

1 reference

12 December 2020

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

12 December 2020

Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM.

1 reference

12 December 2020

Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor.

1 reference

12 December 2020

Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons

1 reference

12 December 2020

Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4

1 reference

12 December 2020

Alzheimer's disease and Down syndrome: leukocyte membrane fluidity alterations

1 reference

12 December 2020

Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis

1 reference

12 December 2020

Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.

1 reference

12 December 2020

Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease.

1 reference

12 December 2020

Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes.

1 reference

12 December 2020

Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging

1 reference

12 December 2020

kappa-1 Opioid receptors of the temporal cortex are preserved in Alzheimer's disease

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1021172620295

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference